Rathnam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 5.73 Cr
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 8.18 Cr
- Revenue Growth 52368.83%
- Profit Growth 53869.57%
- Ebitda 11441.89%
- Net Worth 3.58%
- Total Assets 110.12%
About Rathnam Pharmaceuticals
Rathnam Pharmaceuticals Private Limited (RPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 May 2012 and has a history of 12 years and eight months. Its registered office is in Chittoor, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.73 Cr.
The company currently has active open charges totaling ₹8.18 Cr.
Munirathnam Madithotta and Danamjaya Chinnabba serve as directors at the Company.
Company Details
-
Location
Chittoor, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233AP2012PTC081199
-
Company No.
081199
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2012
-
Date of AGM
13 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Rathnam Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Danamjaya Chinnabba
|
Managing Director | 10-Jun-2013 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Munirathnam Madithotta
|
Director | 30-May-2012 | Current |
Financial Performance of Rathnam Pharmaceuticals.
Rathnam Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 52368.83% increase. The company also saw a substantial improvement in profitability, with a 53869.57% increase in profit. The company's net worth moved up by a moderate rise of 3.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rathnam Pharmaceuticals?
In 2017, Rathnam Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
G.D.M Pharmaceuticals Private LimitedDanamjaya Chinnabba is a mutual person
Charges (Loans)
₹8.18 Cr
₹0
Charges Breakdown by Lending Institutions
- Ifci Venture Capital Funds Limited : 4.18 Cr
- Syndicate Bank : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2017 | Syndicate Bank | ₹4.00 Cr | Open |
| 28 Jan 2016 | Ifci Venture Capital Funds Limited | ₹4.18 Cr | Open |
How Many Employees Work at Rathnam Pharmaceuticals?
Unlock and access historical data on people associated with Rathnam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rathnam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rathnam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
